Actin associated proteins function as androgen receptor coregulators: An implication of androgen receptor's roles in skeletal muscle

Journal of Steroid Biochemistry and Molecular Biology

Volumn 111, Issue 3-5, 2008, Pages 157-163

  Ting, Huei Ju ^a   Chang, Chawnshang ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Actin binding proteins; Androgen receptor; ARA55; Coregulators; Filamin; Gelsolin; Hic 5; Paxillin; Skeletal muscle; Supervillin

Indexed keywords

ACTIN; ACTIN BINDING PROTEIN; ANABOLIC AGENT; ANDROGEN; ANDROGEN RECEPTOR; OXANDROLONE; SELECTIVE ANDROGEN RECEPTOR MODULATOR;

ACTIN FILAMENT; CACHEXIA; CELL PROLIFERATION; CYTOSKELETON; DRUG MECHANISM; DYSTONIA; HUMAN; MUSCLE CELL; MUSCLE DEVELOPMENT; MYOBLAST; NEUROMUSCULAR SYNAPSE; NONHUMAN; PROTEIN FUNCTION; REVIEW; SEX DIFFERENCE; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; WOUND HEALING;

ACTINS; ANDROGENS; HUMANS; MICROFILAMENT PROTEINS; MUSCLE, SKELETAL; RECEPTORS, ANDROGEN; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 49449089292     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2008.06.001     Document Type: Review

References (77)

1. Gao W., Reiser P.J., Coss C.C., Phelps M.A., Kearbey J.D., Miller D.D., and Dalton J.T. Selective androgen receptor modulator treatment improves muscle strength and body composition and prevents bone loss in orchidectomized rats. Endocrinology 146 11 (2005) 4887-4897
2. Miner J.N., Chang W., Chapman M.S., Finn P.D., Hong M.H., Lopez F.J., Marschke K.B., Rosen J., Schrader W., Turner R., van Oeveren A., Viveros H., Zhi L., and Negro-Vilar A. An orally active selective androgen receptor modulator is efficacious on bone, muscle, and sex function with reduced impact on prostate. Endocrinology 148 1 (2007) 363-373
3. Ostrowski J., Kuhns J.E., Lupisella J.A., Manfredi M.C., Beehler B.C., Krystek Jr. S.R., Bi Y., Sun C., Seethala R., Golla R., Sleph P.G., Fura A., An Y., Kish K.F., Sack J.S., Mookhtiar K.A., Grover G.J., and Hamann L.G. Pharmacological and X-ray structural characterization of a novel selective androgen receptor modulator: potent hyperanabolic stimulation of skeletal muscle with hypostimulation of prostate in rats. Endocrinology 148 1 (2007) 4-12
4. Nuclear Receptors Nomenclature Committee, A unified nomenclature system for the nuclear receptor superfamily, Cell 97 (2) (1999) 161-3.
5. MacLean H.E., Warne G.L., and Zajac J.D. Localization of functional domains in the androgen receptor. J. Steroid Biochem. Mol. Biol. 62 4 (1997) 233-242
6. Chang C., Saltzman A., Yeh S., Young W., Keller E., Lee H.J., Wang C., and Mizokami A. Androgen receptor: an overview. Crit. Rev. Eukaryot. Gene. Expr. 5 2 (1995) 97-125
7. Moilanen A., Rouleau N., Ikonen T., Palvimo J.J., and Janne O.A. The presence of a transcription activation function in the hormone-binding domain of androgen receptor is revealed by studies in yeast cells. FEBS Lett. 412 2 (1997) 355-358
8. He B., Kemppainen J.A., Voegel J.J., Gronemeyer H., and Wilson E.M. Activation function 2 in the human androgen receptor ligand binding domain mediates interdomain communication with the NH(2)-terminal domain. J. Biol. Chem. 274 52 (1999) 37219-37225
9. Zhou Z.X., Lane M.V., Kemppainen J.A., French F.S., and Wilson E.M. Specificity of ligand-dependent androgen receptor stabilization: receptor domain interactions influence ligand dissociation and receptor stability. Mol. Endocrinol. 9 2 (1995) 208-218
10. Keller E.T., Ershler W.B., and Chang C. The androgen receptor: a mediator of diverse responses. Front Biosci. 1 (1996) d59-d71
11. Poukka H., Karvonen U., Janne O.A., and Palvimo J.J. Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1). Proc. Natl. Acad. Sci. U.S.A. 97 26 (2000) 14145-14150
12. Wen Y., Hu M.C., Makino K., Spohn B., Bartholomeusz G., Yan D.H., and Hung M.C. HER-2/neu promotes androgen-independent survival and growth of prostate cancer cells through the akt pathway. Cancer Res. 60 24 (2000) 6841-6845
13. Burgdorf S., Leister P., and Scheidtmann K.H. TSG101 interacts with apoptosis-antagonizing transcription factor and enhances androgen receptor-mediated transcription by promoting its monoubiquitination. J. Biol. Chem. 279 17 (2004) 17524-17534
14. Fu M., Wang C., Wang J., Zhang X., Sakamaki T., Yeung Y.G., Chang C., Hopp T., Fuqua S.A., Jaffray E., Hay R.T., Palvimo J.J., Janne O.A., and Pestell R.G. Androgen receptor acetylation governs trans activation and MEKK1-induced apoptosis without affecting in vitro sumoylation and trans-repression function. Mol. Cell Biol. 22 10 (2002) 3373-3388
15. Glass C.K., and Rosenfeld M.G. The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev. 14 2 (2000) 121-141
16. Lee D.K., Duan H.O., and Chang C. From androgen receptor to the general transcription factor TFIIH. Identification of cdk activating kinase (CAK) as an androgen receptor NH(2)-terminal associated coactivator. J. Biol. Chem. 275 13 (2000) 9308-9313
17. Ozanne D.M., Brady M.E., Cook S., Gaughan L., Neal D.E., and Robson C.N. Androgen receptor nuclear translocation is facilitated by the f-actin cross-linking protein filamin. Mol. Endocrinol. 14 10 (2000) 1618-1626
18. Boonyaratanakornkit V., Melvin V., Prendergast P., Altmann M., Ronfani L., Bianchi M.E., Taraseviciene L., Nordeen S.K., Allegretto E.A., and Edwards D.P. High-mobility group chromatin proteins 1 and 2 functionally interact with steroid hormone receptors to enhance their DNA binding in vitro and transcriptional activity in mammalian cells. Mol. Cell Biol. 18 8 (1998) 4471-4487
19. Yeh S., Lin H.K., Kang H.Y., Thin T.H., Lin M.F., and Chang C. From HER2/Neu signal cascade to androgen receptor and its coactivators: a novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells. Proc. Natl. Acad. Sci. U.S.A. 96 10 (1999) 5458-5463
20. Shang Y., and Brown M. Molecular determinants for the tissue specificity of SERMs. Science 295 5564 (2002) 2465-2468
21. Ting H.J., Hu Y.C., and Chang C. Actin monomer enhances supervillin-modulated androgen receptor transactivation. Biochem. Biophys. Res. Commun. 319 2 (2004) 393-396
22. Dube J.Y., Lesage R., and Tremblay R.R. Androgen and estrogen binding in rat skeletal and perineal muscles. Can. J. Biochem. 54 1 (1976) 50-55
23. Joubert Y., Tobin C., and Lebart M.C. Testosterone-induced masculinization of the rat levator ani muscle during puberty. Dev. Biol. 162 1 (1994) 104-110
24. Mooradian A.D., Morley J.E., and Korenman S.G. Biological actions of androgens. Endocr. Rev. 8 1 (1987) 1-28
25. Marin M.L., Tobias M.L., and Kelley D.B. Hormone-sensitive stages in the sexual differentiation of laryngeal muscle fiber number in xenopus laevis. Development 110 3 (1990) 703-711
26. Catz D.S., Fischer L.M., Moschella M.C., Tobias M.L., and Kelley D.B. Sexually dimorphic expression of a laryngeal-specific, androgen-regulated myosin heavy chain gene during xenopus laevis development. Dev. Biol. 154 2 (1992) 366-376
27. Joubert Y., and Tobin C. Satellite cell proliferation and increase in the number of myonuclei induced by testosterone in the levator ani muscle of the adult female rat. Dev. Biol. 131 2 (1989) 550-557
28. Joubert Y., and Tobin C. Testosterone treatment results in quiescent satellite cells being activated and recruited into cell cycle in rat levator ani muscle. Dev. Biol. 169 1 (1995) 286-294
29. Allen R.E., Masak K.C., McAllister P.K., and Merkel R.A. Effect of growth hormone, testosterone and serum concentration on actin synthesis in cultured satellite cells. J. Anim. Sci. 56 4 (1983) 833-837
30. Doumit M.E., Cook D.R., and Merkel R.A. Testosterone up-regulates androgen receptors and decreases differentiation of porcine myogenic satellite cells in vitro. Endocrinology 137 4 (1996) 1385-1394
31. Sinha-Hikim I., Taylor W.E., Gonzalez-Cadavid N.F., Zheng W., and Bhasin S. Androgen receptor in human skeletal muscle and cultured muscle satellite cells: up-regulation by androgen treatment. J. Clin. Endocrinol. Metab. 89 10 (2004) 5245-5255
32. Breedlove S.M. Cellular analyses of hormone influence on motoneuronal development and function. J. Neurobiol. 17 3 (1986) 157-176
33. Powers M.L., and Florini J.R. A direct effect of testosterone on muscle cells in tissue culture. Endocrinology 97 4 (1975) 1043-1047
34. Lee D.K. Androgen receptor enhances myogenin expression and accelerates differentiation. Biochem. Biophys. Res. Commun. 294 2 (2002) 408-413
35. Altuwaijri S., Lee D.K., Chuang K.H., Ting H.J., Yang Z., Xu Q., Tsai M.Y., Yeh S., Hanchett L.A., Chang H.C., and Chang C. Androgen receptor regulates expression of skeletal muscle-specific proteins and muscle cell types. Endocrine 25 1 (2004) 27-32
36. Singh R., Artaza J.N., Taylor W.E., Gonzalez-Cadavid N.F., and Bhasin S. Androgens stimulate myogenic differentiation and inhibit adipogenesis in C3H 10T1/2 pluripotent cells through an androgen receptor-mediated pathway. Endocrinology 144 11 (2003) 5081-5088
37. In: Rogozkin V.A. (Ed). Metabolism of Anabolic Androgenic Steroids (1991), CRC Press Inc., United States
38. Mulligan K., and Schambelan M. Anabolic treatment with GH, IGF-I, or anabolic steroids in patients with HIV-associated wasting. Int. J. Cardiol. 85 1 (2002) 151-159
39. Zhao J., Bauman W.A., Huang R., Caplan A.J., and Cardozo C. Oxandrolone blocks glucocorticoid signaling in an androgen receptor-dependent manner. Steroids 69 5 (2004) 357-366
40. Kamanga-Sollo E., Pampusch M.S., Xi G., White M.E., Hathaway M.R., and Dayton W.R. IGF-I mRNA levels in bovine satellite cell cultures: effects of fusion and anabolic steroid treatment. J. Cell Physiol. 201 2 (2004) 181-189
41. Hartgens F., and Kuipers H. Effects of androgenic-anabolic steroids in athletes. Sports Med. 34 8 (2004) 513-554
42. Kwiatkowski D.J. Functions of gelsolin: motility, signaling, apoptosis, cancer. Curr. Opin. Cell Biol. 11 1 (1999) 103-108
43. Fujita H., Allen P.G., Janmey P.A., Azuma T., Kwiatkowski D.J., Stossel T.P., and Kuzumaki N. Induction of apoptosis by gelsolin truncates. Ann. N.Y. Acad. Sci. 886 (1999) 217-220
44. Nishimura K., Ting H.J., Harada Y., Tokizane T., Nonomura N., Kang H.Y., Chang H.C., Yeh S., Miyamoto H., Shin M., Aozasa K., Okuyama A., and Chang C. Modulation of androgen receptor transactivation by gelsolin: a newly identified androgen receptor coregulator. Cancer Res. 63 16 (2003) 4888-4894
45. Scholz A., and Hinssen H. Biphasic pattern of gelsolin expression and variations in gelsolin-actin interactions during myogenesis. Exp. Cell Res. 219 2 (1995) 384-391
46. Pestonjamasp K.N., Pope R.K., Wulfkuhle J.D., and Luna E.J. Supervillin (p205): a novel membrane-associated, F-actin-binding protein in the villin/gelsolin superfamily. J. Cell Biol. 139 5 (1997) 1255-1269
47. Oh S.W., Pope R.K., Smith K.P., Crowley J.L., Nebl T., Lawrence J.B., and Luna E.J. Archvillin, a muscle-specific isoform of supervillin, is an early expressed component of the costameric membrane skeleton. J. Cell Sci. 116 Pt 11 (2003) 2261-2275
48. Ting H.J., Yeh S., Nishimura K., and Chang C. Supervillin associates with androgen receptor and modulates its transcriptional activity. Proc. Natl. Acad. Sci. U.S.A. 99 2 (2002) 661-666
49. Loy C.J., Sim K.S., and Yong E.L. Filamin-A fragment localizes to the nucleus to regulate androgen receptor and coactivator functions. Proc. Natl. Acad. Sci. U.S.A. 100 8 (2003) 4562-4567
50. Thompson T.G., Chan Y.M., Hack A.A., Brosius M., Rajala M., Lidov H.G., McNally E.M., Watkins S., and Kunkel L.M. Filamin 2 (FLN2): a muscle-specific sarcoglycan interacting protein. J. Cell Biol. 148 1 (2000) 115-126
51. van der Ven P.F., Wiesner S., Salmikangas P., Auerbach D., Himmel M., Kempa S., Hayess K., Pacholsky D., Taivainen A., Schroder R., Carpen O., and Furst D.O. Indications for a novel muscular dystrophy pathway. Gamma-filamin, the muscle-specific filamin isoform, interacts with myotilin. J. Cell Biol. 151 2 (2000) 235-248
52. Goetsch S.C., Martin C.M., Embree L.J., and Garry D.J. Myogenic progenitor cells express filamin C in developing and regenerating skeletal muscle. Stem Cells Dev. 14 2 (2005) 181-187
53. Deshmukh A., Coffey V.G., Zhong Z., Chibalin A.V., Hawley J.A., and Zierath J.R. Exercise-induced phosphorylation of the novel akt substrates AS160 and filamin A in human skeletal muscle. Diabetes 55 6 (2006) 1776-1782
54. Tigges U., Koch B., Wissing J., Jockusch B.M., and Ziegler W.H. The F-actin cross-linking and focal adhesion protein filamin A is a ligand and in vivo substrate for protein kinase C alpha. J. Biol. Chem. 278 26 (2003) 23561-23569
55. Raynaud F., Jond-Necand C., Marcilhac A., Furst D., and Benyamin Y. Calpain 1-gamma filamin interaction in muscle cells: a possible in situ regulation by PKC-alpha. Int. J. Biochem. Cell Biol. 38 3 (2006) 404-413
56. Kwak K.B., Chung S.S., Kim O.M., Kang M.S., Ha D.B., and Chung C.H. Increase in the level of m-calpain correlates with the elevated cleavage of filamin during myogenic differentiation of embryonic muscle cells. Biochim. Biophys. Acta 1175 3 (1993) 243-249
57. Matsuya M., Sasaki H., Aoto H., Mitaka T., Nagura K., Ohba T., Ishino M., Takahashi S., Suzuki R., and Sasaki T. Cell adhesion kinase beta forms a complex with a new member, hic-5, of proteins localized at focal adhesions. J. Biol. Chem. 273 2 (1998) 1003-1014
58. Taira M., Evrard J.L., Steinmetz A., and Dawid I.B. Classification of LIM proteins. Trends Genet. 11 11 (1995) 431-432
59. Kadrmas J.L., and Beckerle M.C. The LIM domain: from the cytoskeleton to the nucleus. Nat. Rev. Mol. Cell Biol. 5 11 (2004) 920-931
60. Muller J.M., Isele U., Metzger E., Rempel A., Moser M., Pscherer A., Breyer T., Holubarsch C., Buettner R., and Schule R. FHL2, a novel tissue-specific coactivator of the androgen receptor. EMBO J. 19 3 (2000) 359-369
61. Fujimoto N., Yeh S., Kang H.Y., Inui S., Chang H.C., Mizokami A., and Chang C. Cloning and characterization of androgen receptor coactivator, ARA55, in human prostate. J. Biol. Chem. 274 12 (1999) 8316-8321
62. Kasai M., Guerrero-Santoro J., Friedman R., Leman E.S., Getzenberg R.H., and DeFranco D.B. The group 3 LIM domain protein paxillin potentiates androgen receptor transactivation in prostate cancer cell lines. Cancer Res. 63 16 (2003) 4927-4935
63. Hsu C.L., Chen Y.L., Yeh S., Ting H.J., Hu Y.C., Lin H., Wang X., and Chang C. The use of phage display technique for the isolation of androgen receptor interacting peptides with (F/W)XXL(F/W) and FXXLY new signature motifs. J. Biol. Chem. 278 26 (2003) 23691-23698
64. Wang X., Yang Y., Guo X., Sampson E.R., Hsu C.L., Tsai M.Y., Yeh S., Wu G., Guo Y., and Chang C. Suppression of androgen receptor transactivation by Pyk2 via interaction and phosphorylation of the ARA55 coregulator. J. Biol. Chem. 277 18 (2002) 15426-15431
65. Shibanuma M., Kim-Kaneyama J.R., Ishino K., Sakamoto N., Hishiki T., Yamaguchi K., Mori K., Mashimo J., and Nose K. Hic-5 communicates between focal adhesions and the nucleus through oxidant-sensitive nuclear export signal. Mol. Biol. Cell 14 3 (2003) 1158-1171
66. Shibanuma M., Mori K., Kim-Kaneyama J.R., and Nose K. Involvement of FAK and PTP-PEST in the regulation of redox-sensitive nuclear-cytoplasmic shuttling of a LIM protein, hic-5. Antioxid. Redox Signal 7 3-4 (2005) 335-347
67. Shibanuma M., Iwabuchi Y., and Nose K. Possible involvement of hic-5, a focal adhesion protein, in the differentiation of C2C12 myoblasts. Cell Struct. Funct. 27 1 (2002) 21-27
68. Hu Y., Cascone P.J., Cheng L., Sun D., Nambu J.R., and Schwartz L.M. Lepidopteran DALP, and its mammalian ortholog HIC-5, function as negative regulators of muscle differentiation. Proc. Natl. Acad. Sci. U.S.A. 96 18 (1999) 10218-10223
69. Gao Z.L., Deblis R., Glenn H., and Schwartz L.M. Differential roles of HIC-5 isoforms in the regulation of cell death and myotube formation during myogenesis. Exp. Cell Res. (2007)
70. Turner C.E. Paxillin interactions. J. Cell. Sci 113 Pt. 23 (2000) 4139-4140
71. Cai X., Li M., Vrana J., and Schaller M.D. Glycogen synthase kinase 3- and extracellular signal-regulated kinase-dependent phosphorylation of paxillin regulates cytoskeletal rearrangement. Mol. Cell Biol. 26 7 (2006) 2857-2868
72. Turner C.E., Kramarcy N., Sealock R., and Burridge K. Localization of paxillin, a focal adhesion protein, to smooth muscle dense plaques, and the myotendinous and neuromuscular junctions of skeletal muscle. Exp. Cell Res. 192 2 (1991) 651-655
73. Quach N.L., and Rando T.A. Focal adhesion kinase is essential for costamerogenesis in cultured skeletal muscle cells. Dev. Biol. 293 1 (2006) 38-52
74. Yuminamochi T., Yatomi Y., Osada M., Ohmori T., Ishii Y., Nakazawa K., Hosogaya S., and Ozaki Y. Expression of the LIM proteins paxillin and hic-5 in human tissues. J. Histochem. Cytochem. 51 4 (2003) 513-521
75. Sastry S.K., Lakonishok M., Wu S., Truong T.Q., Huttenlocher A., Turner C.E., and Horwitz A.F. Quantitative changes in integrin and focal adhesion signaling regulate myoblast cell cycle withdrawal. J. Cell Biol. 144 6 (1999) 1295-1309
76. Gordon S.E., Fluck M., and Booth F.W. Selected contribution: skeletal muscle focal adhesion kinase, paxillin, and serum response factor are loading dependent. J. Appl. Physiol. 90 3 (2001) 1174-1183 discussion 1165
77. Goel H.L., and Dey C.S. PKC-regulated myogenesis is associated with increased tyrosine phosphorylation of FAK, cas, and paxillin, formation of cas-CRK complex, and JNK activation. Differentiation 70 6 (2002) 257-271